Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation

Complimentary

Released on 3/12/25
Expires on 3/12/26

Categories: , , , , , , ,
Close-up of a human eye with a futuristic digital interface overlay.

Start Activity

Program Description

This webcast provides an update on the ocular surface diseases. Cornea and conjunctiva, lids, exocrine glands and their innervation form an integrated entity, which regulates the production of tear fluid.1 Stable tear fluid is essential in nourishing and protecting the ocular surface from external threats, such as pollution, desiccation, injuries, allergens and pathogens. Maintaining and protecting the transparent, avascular cornea is particularly important for good visual acuity. Thus, an integral part of the functioning of the ocular surface relies on the tear fluid.

Intended Audience

Ophthalmologists, optometrists, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with ocular surfaces diseases.

Commercial Supporter

This activity is supported by an educational grant from Dompé US Inc.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Summarize the pathophysiology, risk factor, and evaluation of ocular surface disease
  • Interpret data on artificial tear formulations and neuromodulation in managing ocular surface disease

Accredited Providers

This activity is provided by Amedco and MedNet.

      

Joint Accreditation Statement

In support of improving patient care, Amedco and MedNet have planned and implemented this activity. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. MedNet serves as the content and logistic provider for this activity. Amedco designates this activity for 1.25 AMA PRA Category 1 CreditsTM

Physicians Credit Designation

Amedco designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Credit Information

Physician Assistants
AAPA accepts AMA PRA Category 1 CreditTM for the PRA from organizations accredited by ACCME. Maximum of 1.25 hours.

Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors, and allows reciprocity for AANPCP continuing education credit. Maximum of 1.25 hours.

Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians and healthcare providers may convert CME/CE PRA Category 1 CreditsTM to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has recognition agreements with the AMA for live events and e-learning materials.

Faculty

Sarah B. Sunshine, MD
Assistant Professor, Ophthalmology
University of Maryland and Greenebaum Comprehensive Cancer
Baltimore, MD

Dr. Sunshine discloses the following:
Consultant: Astra Zeneca, GSK
Research Support: Incyte (IIT), Eversight, NIH

Instructions

In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.

ACCME – Amedco
Phone Number: 651-789-3730
E-Mail: Sheryl@amedcoemail.com

Privacy Policy

myCME privacy policy

Webcast

Time to Complete: 75 minutes

Released: March 12, 2025

Expires: March 12, 2026

Maximum Credits:
1.25 / AMA PRA Category 1 CreditsTM

Related products